New Key Statistics Module, Z-Score and F-Score
NAS:NTLA Key Ratios
Market Cap $ M | 1,792.87 |
Enterprise Value $ M | 1,234.51 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.79 |
Price/Sales | 36.68 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 45.00 |
EPS (TTM) $ | -5.48 |
Beneish M-Score | -1.24 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -28.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.36 |
EV-to-EBITDA | -2.40 |
PEG | -- |
Shares Outstanding M | 101.58 |
Net Margin (%) | -1,106.87 |
Operating Margin % | -1,140.05 |
Pre-tax Margin (%) | -1,106.87 |
Quick Ratio | 7.21 |
Current Ratio | 7.21 |
ROA % (ttm) | -40.26 |
ROE % (ttm) | -48.93 |
ROIC % (ttm) | -123.21 |
Dividend Yield % | -- |
Altman Z-Score | 1.99 |
NTLA Number of Guru Trades
NTLA Volume of Guru Trades
Gurus Latest Trades with NAS:NTLA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NTLA is held by these investors
Total 1
Intellia Therapeutics Inc Insider Transactions
No Available Data
News about NAS:NTLA
Total 0- 1